How many insider declarations does Lexicon Pharmaceuticals, INC. have?

Lexicon Pharmaceuticals, INC. has filed 15 insider declarations with SEC (Form 4).

Who is the top reporting insider at Lexicon Pharmaceuticals, INC.?

The top reporting insider at Lexicon Pharmaceuticals, INC. is DEBBANE RAYMOND, based on the count of public filings.

What is the net insider buy vs sell volume on Lexicon Pharmaceuticals, INC.?

Across the available history, declared buys total 0 and disposals 0.

InsiderTradesSIGMA

InsidersTradesSigma

Lexicon Pharmaceuticals, INC. (LXRX) — directors' dealings

← Companies ★ Sign in to follow

Lexicon Pharmaceuticals, INC.: directors' dealings · United States · SEC (Form 4)

SEC:lexicon-pharmaceuticals-inc-31d6c9US·SEC (Form 4)Mcap 944M€Healthcare

AMF ↗

Explore the full insider trade history of Lexicon Pharmaceuticals, INC., a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Lexicon Pharmaceuticals, INC. has recorded 15 insider filings. Market capitalisation: €943.9m. The latest transaction was filed on 2 May 2022 — Levée d'options. Among the most active insiders: DEBBANE RAYMOND. All data is openly available.

Insider Decl.

Thresholds

0 ops.

Buy Volume

0 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

2.13 €

Analyst consensus

5 analysts

Buy

1.50 €Target 3.72 €(+75%)6.00 €

Income statement

Revenue49.8 M€

Gross profit49.5 M€99% margin

Net income−50.3 M€-101.1% margin

Valuation

PER (forward)-10.3x

P/Book7.2x

Beta0.97

Balance sheet & cash

Market cap943.9 M€

Total debt62.8 M€

Free Cash Flow−67.9 M€

Debt / Equity58%

Profitability & ownership

ROE-39.7%

ROA-12.6%

% insiders1.0%

% institutions65.2%

Last declaration on 2 May 2022

All Executives15 Thresholds Prospectus Other

Declarations15 total

Executives◇Options16SEC

DEBBANE RAYMONDDirector

04,024 shares0

Common Stock

SEC:0001127602-22-012827:0·30 Apr 2022